Recent advances in biomarkers for detection and diagnosis of sepsis and organ dysfunction: a comprehensive review

Sepsis is life-threatening inflammatory disease, and its pathogenesis and prognostic factors remain unclear. In addition, the symptoms and signs of sepsis patients lack specificity, which makes the diagnosis, treatment and prognosis evaluation of sepsis extremely difficult. Recently, with the emergence and development of detection technologies, various sepsis-related biomarkers have emerged. Biomarkers could be considered as indicators of either infection or dysregulated host response or response to treatment and/or aid clinicians to prognosticate patient risk. Therefore, searching for reliable biomarkers and evaluating their role in sepsis is envisaged to aid clinical decision-making. This article reviews the advances in research on sepsis biomarkers and their application in the early prediction of organ dysfunction to improve our understanding of current sepsis biomarkers and provide a reference for the application of biomarkers in the clinical diagnosis, treatment, and prognosis of sepsis. Besides, we propose that the combining multiple biomarkers is expected to be a more accurate and comprehensive strategy to evaluate the condition and prognosis of sepsis patients.

• Publication year

  2025

• Venue

  European Journal of Medical Research

• Publication date

  2025-11-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/s40001-025-03324-6PMID 41204362PMCID 12595651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in Research Pertaining to Biomarkers for Myocardial Injury in Sepsis.

  2025cited by this paper
• Transforming sepsis management: AI-driven innovations in early detection and tailored therapies

  2025cited by this paper
• Serum Exosomes miR-122-5P Induces Hepatic and Renal Injury in Septic Rats by Regulating TAK1/SIRT1 Pathway

  2025cited by this paper
• Metabolomics- and proteomics-based multi-omics integration reveals early metabolite alterations in sepsis-associated acute kidney injury

  2025cited by this paper
• Accuracy of blood heparin-binding protein (HBP) for diagnosis bacteremia in patients with sepsis

  2025cited by this paper
• Identifying early predictive and diagnostic biomarkers and exploring metabolic pathways for sepsis after trauma based on an untargeted metabolomics approach

  2025influential reference
• Heart-type fatty acid binding protein (H-FABP) as an early biomarker in sepsis-induced cardiomyopathy: a prospective observational study

  2024cited by this paper
• Evaluation of glutamate dehydrogenase (GLDH) as a diagnostic and prognostic marker in drug-induced liver injury

  2024cited by this paper
• Diagnosis of sepsis: which clinical and laboratory biomarkers are useful?

  2024cited by this paper
• Septic shock in the prehospital setting: a scoping review

  2024cited by this paper
• Integrated multi-omics and artificial intelligence to explore new neutrophils clusters and potential biomarkers in sepsis with experimental validation

  2024cited by this paper
• Surviving Sepsis Campaign Research Priorities 2023

  2024cited by this paper
• A biomarker panel of C-reactive protein, procalcitonin and serum amyloid A is a predictor of sepsis in severe trauma patients

  2024cited by this paper
• Sepsis, Management & Advances in Metabolomics

  2024cited by this paper
• Integrated analysis of single-cell RNA-seq and chipset data unravels PANoptosis-related genes in sepsis

  2024cited by this paper
• qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial

  2024cited by this paper
• Biomarkers in sepsis.

  2024cited by this paper
• Diagnostic and prognostic value of heparin-binding protein in sepsis: A systematic review and meta-analysis

  2024cited by this paper
• Early Diagnosis of Sepsis: The Role of Biomarkers and Rapid Microbiological Tests

  2024cited by this paper
• Advances in metabolomics in critically ill patients with sepsis and septic shock

  2024cited by this paper
• Diagnostic and prognostic value of serum S100B in sepsis-associated encephalopathy: A systematic review and meta-analysis

  2023cited by this paper
• Current insight on the mechanisms of programmed cell death in sepsis-induced myocardial dysfunction

  2023cited by this paper
• Longitudinal NMR Based Serum Metabolomics to Track the Potential Serum Biomarkers of Septic Shock

  2023cited by this paper
• Biomarkers in Sepsis: A Current Review of New Technologies

  2023cited by this paper
• Sepsis-associated encephalopathy: From pathophysiology to clinical management.

  2023cited by this paper
• Comparison between presepsin, procalcitonin, and CRP as biomarkers to diagnose sepsis in critically ill patients

  2023cited by this paper
• Serum HMGB1 and soluble urokinase plasminogen activator receptor levels aid diagnosis and prognosis prediction of sepsis with acute respiratory distress syndrome.

  2023cited by this paper
• Analysis and validation of diagnostic biomarkers and immune cell infiltration characteristics in pediatric sepsis by integrating bioinformatics and machine learning

  2023cited by this paper
• Evaluation of qSOFA Combined with Inflammatory Mediators for Diagnosing Sepsis and Predicting Mortality among Emergency Department.

  2023cited by this paper
• Single-cell RNA sequencing and transcriptomic analysis reveal key genes and regulatory mechanisms in sepsis

  2023cited by this paper
• Effect of HMGB1 and HBD-3 levels in the diagnosis of sepsis- A comparative descriptive study

  2023cited by this paper
• Correlation of Surfactant Protein-D (SP-D) Serum Levels with ARDS Severity and Mortality in Covid-19 Patients in Indonesia

  2022influential reference
• Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)

  2022cited by this paper
• Sepsis biomarkers and diagnostic tools with a focus on machine learning

  2022cited by this paper
• The Value of Neutrophil/Lymphocyte Ratio Combined with Red Blood Cell Distribution Width in Evaluating the Prognosis of Emergency Patients with Sepsis

  2022cited by this paper
• Decreased Monocyte HLA-DR Expression in Patients with Sepsis and Acute Kidney Injury

  2022cited by this paper
• Diagnostic and Prognostic Value of Interleukin-6 in Emergency Department Sepsis Patients

  2022cited by this paper
• TREM-1 Modulation Strategies for Sepsis

  2022cited by this paper
• Diagnostic and prognostic predictive values of circulating sTREM-1 in sepsis: A meta-analysis.

  2021influential reference
• Evaluation of sTREM1 and suPAR Biomarkers as Diagnostic and Prognostic Predictors in Sepsis Patients

  2021cited by this paper
• Postmortem Evidence of Brain Inflammatory Markers and Injury in Septic Patients: A Systematic Review

  2021cited by this paper
• Sepsis-Associated Encephalopathy and Blood-Brain Barrier Dysfunction

  2021cited by this paper
• Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury

  2021cited by this paper
• The prognostic impact of the serum heart-type fatty acid-binding protein level in patients with sepsis who were admitted to the non-surgical intensive-care unit

  2021cited by this paper
• Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental animal model of sepsis.

  2021cited by this paper
• The pathogenesis and diagnosis of sepsis post burn injury

  2021cited by this paper
• Optimal combination of early biomarkers for infection and sepsis diagnosis in the emergency department: the BIPS study.

  2021influential reference
• Serum metabolic profiles of septic shock patients based upon co-morbidities and other underlying conditions.

  2021cited by this paper
• Heparin Binding Protein for the Early Diagnosis and Prognosis of Sepsis in the Emergency Department: The Prompt Multicenter Study

  2021cited by this paper
• The blood-brain barrier dysfunction in sepsis

  2020cited by this paper
• The Diagnostic and Prognostic Value of suPAR in Patients with Sepsis: A Systematic Review and Meta-Analysis

  2020cited by this paper
• Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study

  2020cited by this paper
• Heart-Type Fatty Acid-Binding Protein (H-FABP) and Its Role as a Biomarker in Heart Failure: What Do We Know So Far?

  2020cited by this paper
• Neutrophil Volume, conductivity and scatter (VCS) as a screening tool in neonatal sepsis

  2020cited by this paper
• Utility of sTREM-1 and Presepsin (sCD14-ST) as Diagnostic and Prognostic Markers of Sepsis.

  2020cited by this paper
• Surfactant Protein D is Associated with Severe Pediatric Acute Respiratory Distress Syndrome, Prolonged Ventilation, and Death in Children with Acute Respiratory Failure.

  2020cited by this paper
• Soluble CD14 Subtype in Peripheral Blood is a Biomarker for Early Diagnosis of Sepsis.

  2020cited by this paper
• Biomarker combination and SOFA score for the prediction of mortality in sepsis and septic shock

  2020influential reference
• Biomarkers of sepsis: time for a reappraisal

  2020cited by this paper
• Sepsis and Septic Shock - Basics of diagnosis, pathophysiology and clinical decision making.

  2020cited by this paper
• sTREM-1 predicts mortality in hospitalized patients with infection in a tropical, middle-income country

  2020cited by this paper
• Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients

  2020cited by this paper
• Multi-biomarker strategy for prediction of myocardial dysfunction and mortality in sepsis

  2020cited by this paper
• Heart-type fatty acid-binding protein: an overlooked cardiac biomarker

  2020cited by this paper
• Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement.

  2020cited by this paper
• Echocardiography versus cardiac biomarkers for myocardial dysfunction in children with scorpion envenomation: An observational study from tertiary care center in northern India.

  2020cited by this paper
• Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019

  2020cited by this paper
• High Mobility Group box-1 (HMGB1) Protein As a Biomarker for Acute Cholecystitis.

  2019cited by this paper
• Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study

  2019cited by this paper
• Role of High-Mobility Group Box-1 in Liver Pathogenesis

  2019cited by this paper
• Liver impairment in critical illness and sepsis: the dawn of new biomarkers?

  2019cited by this paper
• Late Peaks of HMGB1 and Sepsis Outcome: Evidence for Synergy With Chronic Inflammatory Disorders.

  2019cited by this paper
• High Mobility Group Box 1: An Immune-regulatory Protein

  2019cited by this paper
• Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation

  2019cited by this paper
• Long-term Host Immune Response Trajectories Among Hospitalized Patients With Sepsis

  2019cited by this paper
• Dynamic changes in human HLA‐DRA gene expression and Th cell subsets in sepsis: Indications of immunosuppression and associated outcomes

  2019cited by this paper
• Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment.

  2019cited by this paper
• Proposal of a two‐step process for the diagnosis of sepsis‐induced disseminated intravascular coagulation

  2019cited by this paper
• Combined Biomarkers Predict Acute Mortality Among Critically Ill Patients With Suspected Sepsis*

  2018cited by this paper
• Prognostic value of the biomarkers serum amyloid A and nitric oxide in patients with sepsis

  2018cited by this paper
• Sepsis: who will shoot first? Pharma or diagnostics?

  2018cited by this paper
• Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis

  2018cited by this paper
• Mechanisms and treatment of organ failure in sepsis

  2018cited by this paper
• Acute Kidney Injury and Sepsis

  2018cited by this paper
• Recognizing Sepsis as a Global Health Priority - A WHO Resolution.

  2017influential reference
• The long pentraxin PTX3: A prototypical sensor of tissue injury and a regulator of homeostasis

  2017cited by this paper
• Diagnostic and prognostic values of Club cell protein 16 (CC16) in critical care patients with acute respiratory distress syndrome

  2017cited by this paper
• Is serum high-mobility group box 1 (HMGB-1) level correlated with liver fibrosis in chronic hepatitis B?

  2017cited by this paper
• Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis

  2016cited by this paper
• Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations.

  2016cited by this paper
• Prognostic Value of Plasma Tight-Junction Proteins for Sepsis in Emergency Department: an Observational Study

  2016cited by this paper
• Diagnostic and prognostic value of procalcitonin and sTREM-1 levels in sepsis.

  2015cited by this paper
• The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

  2015cited by this paper
• Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.

  2014cited by this paper
• Procalcitonin as a diagnostic marker for sepsis.

  2014cited by this paper
• Measuring both procalcitonin and C-reactive protein for a diagnosis of sepsis in critically ill patients

  2014cited by this paper
• An Update on the Use of C-Reactive Protein in Early-Onset Neonatal Sepsis: Current Insights and New Tasks

  2012cited by this paper
• Plasma angiopoietin-2 in clinical acute lung injury: Prognostic and pathogenetic significance*

  2012cited by this paper
• Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.

  2010cited by this paper
• Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury.

  2010cited by this paper

• Extracellular Vesicle-Derived MicroRNAs’ Value in Diagnosing and Predicting Clinical Outcomes in Patients with COVID-19 and Bacterial Sepsis

  2026cites this paper
• Tenascin-C, presepsin (sCD14-ST), and neutrophil-to-lymphocyte ratio as complementary circulating biomarkers for sepsis-associated organ dysfunction and 28-day all-cause mortality: a biomarker-enriched prognostic model

  2026cites this paper
• Corticosteroids, Rifampicin and LMWH impact plasma aMMP-8 and TIMP-1 and aMMP-8/TIMP-1 molar ratio in methicillin-sensitive Staphylococcus aureus bacteraemia.

  2025cites this paper
• Quantification of the Actin-Binding Protein Flightless-I in Human Serum by Automated Western Blot System and Investigation of Its Diagnostic Potential in Sepsis

  2025cites this paper
• Sepsis-Biomarker: Hämatologische Scores im Überblick

  2025cites this paper
• Multidisciplinary Management Of Acute Sepsis Correlating Nursing Clinical Indicators With Rapid Laboratory Biomarkers And Radiologic Imaging Findings

  2024influential citation